Roman Maresch

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes

Sebastian Mueller, Thomas Engleitner, Roman Maresch et al. · Nature · 2018 · 431 citations · Full text

Pancreatic Cancer, Evolutionary Routes, Medicine +4

PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis

Tim Wartewig, Zsuzsanna Kurgyis, Selina J. Keppler et al. · Nature · 2017 · 243 citations · Full text

Immunology, T Cell Lymphomagenesis, Autoimmunity +4

CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice

Julia Weber, Rupert Öllinger, Mathias Friedrich et al. · Proceedings of the National Academy of Sciences · 2015 · 192 citations · Full text

Engineering, Genetics, Crispr/cas9 Somatic Multiplex-mutagenesis +16

Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice

Roman Maresch, Sebastian Mueller, Christian Veltkamp et al. · Nature Communications · 2016 · 171 citations · Full text

Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment

Chiara Falcomatà, Stefanie Bärthel, Sebastian A. Widholz et al. · Nature Cancer · 2022 · 101 citations · Full text

Cancer Immunosurveillance, Pancreatic Cancer, Selective Multi-kinase Inhibition +9